Aria Biosystems

Aria Biosystems was a life science technology company that specialized in the development of advanced flow cytometry and high-speed cell sorting systems. Founded in the late 1990s, the company focused on creating digital electronics and fluidics that could significantly enhance the speed and accuracy of cell isolation. In January 2002, the company was acquired by BD Biosciences, a segment of Becton, Dickinson and Company. The core technology developed by Aria Biosystems served as the foundation for the BD FACSAria, which became a benchmark instrument in immunology and stem cell research. This acquisition was pivotal in transitioning flow cytometry from a highly specialized niche to a standard laboratory tool. The company's innovations allowed for the automation of complex sorting tasks, making high-performance cell analysis accessible to a broader range of scientific researchers.